Department of Neurosurgery, Acıbadem Mehmet Ali Aydınlar University, School of Medicine, Istanbul, Turkey.
Vezirköprü State Hospital, Neurosurgery Clinic, Samsun, Turkey.
World Neurosurg. 2019 Dec;132:e350-e365. doi: 10.1016/j.wneu.2019.08.150. Epub 2019 Aug 30.
Improved life expectancy and advanced diagnostic tools including computed tomography and magnetic resonance imaging have increased the awareness and diagnosis of intracranial meningiomas in the elderly population. The risk/benefit ratio of surgery in elderly patients with intracranial meningioma has not been clearly defined because of the lack of objective measurement tools. We aimed to understand the risk factors associated with postsurgical outcomes and how these risk factors affected postsurgical outcomes in elderly patients with intracranial meningioma.
We retrospectively evaluated 1372 patients, who were operated on for intracranial meningioma, using our prospectively collected database. The same senior author operated on all patients at 2 different tertiary clinics. Patients' clinical charts, presurgical postcontrast T1-weighted magnetic resonance images, operative reports, and pathology reports were reviewed. The relevant literature was also reviewed.
Higher age, higher American Society of Anesthesiologists class, presence of comorbidities, tumor location, larger initial tumor size, and presence of peritumoral edema were all associated with postsurgical complications in elderly patients with intracranial meningioma. Age ≥50 years was the strongest predictor of postsurgical systemic complications, whereas higher American Society of Anesthesiologists class was the strongest predictor of postsurgical neurologic complications. A literature review showed higher morbidity and mortality of elderly patients with intracranial meningioma. Initial tumor size and postsurgical MIB-1 labeling index were higher in the elderly patients, both of which were predictors of tumor growth.
Even though elderly patients operated on for intracranial meningioma had higher morbidity and mortality compared with younger patients, surgery is still much more beneficial than wait-and-see strategy in elderly patients.
预期寿命的提高和包括计算机断层扫描和磁共振成像在内的先进诊断工具提高了老年人颅内脑膜瘤的认识和诊断。由于缺乏客观的测量工具,老年颅内脑膜瘤患者手术的风险/效益比尚未明确界定。我们旨在了解与术后结果相关的危险因素,以及这些危险因素如何影响老年颅内脑膜瘤患者的术后结果。
我们使用前瞻性收集的数据库回顾性评估了 1372 名接受颅内脑膜瘤手术的患者。同一位资深作者在 2 家不同的三级诊所为所有患者进行了手术。对患者的临床病历、术前对比增强 T1 加权磁共振成像、手术报告和病理报告进行了审查。还回顾了相关文献。
较高的年龄、较高的美国麻醉医师协会(American Society of Anesthesiologists,ASA)分级、合并症、肿瘤位置、较大的初始肿瘤大小和肿瘤周围水肿的存在与老年颅内脑膜瘤患者的术后并发症相关。年龄≥50 岁是术后全身并发症的最强预测因素,而较高的 ASA 分级是术后神经并发症的最强预测因素。文献复习显示,老年颅内脑膜瘤患者的发病率和死亡率较高。老年患者的初始肿瘤大小和术后 MIB-1 标记指数较高,两者都是肿瘤生长的预测因素。
尽管与年轻患者相比,接受颅内脑膜瘤手术的老年患者的发病率和死亡率较高,但手术对老年患者的益处仍远大于观望策略。